Janssen’s depression nasal spray Spravato bags new FDA approval
Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour
Read More
Author: Lucy Parsons
Oxford Biomedica and Beam Therapeutics sign CAR-T deal
Agreement will utilise Oxford Biomedica’s LentiVector platform
Read More
Roche’s tumour-agnostic therapy Rozlytrek approved in EU
Therapy has been approved to treat advanced NTRK fusion-positive solid tumours
Read More
UK increases COVID-19 vaccine manufacturing capacity
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
Read More
Immodulon, Champalimaud Foundation team up on ‘difficult to treat’ cancers
Collaboration will explore experimental treatment IMM-101 in combination with other therapies in advanced cancers
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
